seen from India
seen from Malaysia
seen from India
seen from United States
seen from South Korea
seen from United States
seen from China
seen from United States
seen from Ukraine
seen from Australia
seen from United States
seen from United States
seen from China
seen from New Zealand
seen from France
seen from Malaysia
seen from Malaysia
seen from China
seen from United States
seen from Germany
Top M&A Deals in 2024
Pharmaceutical and biotech giants are making big investments in antibody-drug conjugates (ADCs) through strategic M&A and collaborations. These high-value deals highlight the growing role of targeted cancer therapies, shaping the future of oncology treatment.
